Application of an evidence-based, out-patient treatment strategy for COVID-19: Multidisciplinary medical practice principles to prevent severe disease.

作者: Oleg Komogortsev , Robert Glanzman , Audrey R. Frohman , Matthew S. Parsons , Matthew S. Parsons

DOI: 10.1016/J.JNS.2021.117463

关键词: PandemicCoronavirus disease 2019 (COVID-19)Evidence-based practiceVaccine failurePolitical sciencePublic relationsPopulationResistance (psychoanalysis)Multidisciplinary approachAdversary

摘要: The COVID-19 pandemic has devastated individuals, families, and institutions throughout the world. Despite breakneck speed of vaccine development, human population remains at risk further devastation. decision to not become vaccinated, protracted rollout available vaccine, failure, mutational forms SARS virus, which may exhibit mounting resistance our molecular strike only one form viral family, rapid ability virus(es) hitch a ride on global transportation systems, means that we are will likely continue confront an invisible, yet devastating foe. enemy targets physiology's most important vulnerable life-preserving body tissues, broncho-alveolar gas exchange apparatus. Notwithstanding fear fury this microbe's potential raise existential questions across entire spectrum endeavor, application early treatment intervention initiative represent crucial tool in defensive strategy. This strategy is driven by evidence-based medical practice principles, those antiquated, given diversity evolution very clever "world traveler".

参考文章(113)
Carlos E. Milla, Leland G. Hansen, Warren J. Warwick, Adam Weber, High-frequency chest compression: effect of the third generation compression waveform. Biomedical Instrumentation & Technology. ,vol. 38, pp. 322- 328 ,(2004) , 10.2345/0899-8205(2004)38[322:HCCEOT]2.0.CO;2
John R. Klune, Rajeev Dhupar, Jon Cardinal, Timothy R. Billiar, Allan Tsung, HMGB1: endogenous danger signaling. Molecular Medicine. ,vol. 14, pp. 476- 484 ,(2008) , 10.2119/2008-00034.KLUNE
Sally Thomas, Katherine H. Fisher, John A. Snowden, Sarah J. Danson, Stephen Brown, Martin P. Zeidler, Methotrexate Is a JAK/STAT Pathway Inhibitor PLOS ONE. ,vol. 10, pp. e0130078- ,(2015) , 10.1371/JOURNAL.PONE.0130078
Ching-Piao Tsai, Feng-Cheng Lin, Charles Tzu-Chi Lee, Beta2-adrenergic agonist use and the risk of multiple sclerosis: a total population-based case-control study. Multiple Sclerosis Journal. ,vol. 20, pp. 1593- 1601 ,(2014) , 10.1177/1352458514528758
Hyung-Sik Kang, Inpyo Choi, Sang-Deok Lim, June-Kyu Lee, Jeong-Ho Seok, Jae-Heun Lee, Gang-Min Hur, Ji-Yeon Sung, Jang-Hee Hong, Methotrexate suppresses the interleukin-6 induced generation of reactive oxygen species in the synoviocytes of rheumatoid arthritis Immunopharmacology. ,vol. 47, pp. 35- 44 ,(2000) , 10.1016/S0162-3109(99)00185-X
Colin K. Grissom, Eliotte L. Hirshberg, Justin B. Dickerson, Samuel M. Brown, Michael J. Lanspa, Kathleen D. Liu, David Schoenfeld, Mark Tidswell, R. Duncan Hite, Peter Rock, Russell R. Miller, Alan H. Morris, Fluid management with a simplified conservative protocol for the acute respiratory distress syndrome Critical Care Medicine. ,vol. 43, pp. 288- 295 ,(2015) , 10.1097/CCM.0000000000000715
Karim Makhlouf, Manuel Comabella, Jaime Imitola, Howard L Weiner, Samia J Khoury, Oral salbutamol decreases IL-12 in patients with secondary progressive multiple sclerosis Journal of Neuroimmunology. ,vol. 117, pp. 156- 165 ,(2001) , 10.1016/S0165-5728(01)00322-8
ANGELIKA BIERHAUS, PER M. HUMPERT, DAVID M. STERN, BERND ARNOLD, PETER P. NAWROTH, Advanced Glycation End Product Receptor‐Mediated Cellular Dysfunction Annals of the New York Academy of Sciences. ,vol. 1043, pp. 676- 680 ,(2005) , 10.1196/ANNALS.1333.077